Together, our team combines expertise in clinical medicine, pharmacology, artificial intelligence, biochemistry and regulatory affairs to drive excellence and sustainability in venom research.
Pipeline
Key Partners
Academic Institutions and Research Centres
Academic institutions and research centres participating in the COST Action IG19144, forming the core VENOVATE consortium.
Industrial Partners
Established industrial partners and specialised companies contributing expertise, platforms, or services relevant to venom biodiscovery and translation.
IP and Legal Advisory Partners
IP and legal advisory partners supporting intellectual property awareness, protection pathways, and valorisation strategies.
European Research and Innovation Networks
European research and innovation networks linked to COST and EU programmes (e.g. STSMs, training schools, VMGs, dissemination activities).
Roles and Contributions
Scientific partners
Provide domain expertise, experimental platforms, protocols, and access to
state-of-the-art infrastructure (e.g. HTS, in vitro/in vivo models).
Industrial partners
Contribute translational insight, feasibility assessment, and alignment with
market and regulatory expectations.
IP partners
Support IP strategy, freedom-to-operate awareness, and exploitation routes for consortium and client projects.
COST framework
Enables coordination, mobility, governance, and efficient collaboration across countries.
Partners strengths
Scientific excellence
Proven scientific excellence and reputation in venom research and biomedical innovation.
Multidisciplinary expertise
Complementary multidisciplinary expertise spanning discovery, validation, in silico analysis, production, and commercialisation.
Access to infrastructure
Access to advanced infrastructure and equipment without the need for dedicated capital investment.
Collaboration culture
Strong culture of collaboration, standardisation, and knowledge sharing established through COST.
